Public Documents

 
Public Documents - All Categories

Drug Injury Watch: Testosterone Injections Or Shots Such As Depo-Testosterone Might Have Higher Risks Of Heart Attacks, Strokes, And Deaths New Medical Research Suggests The Safety Of A Testosterone Drug Might Depend On Its Form: Injections / Shots; Creams / Gels; Skin Patches http://www.drug-injury.com/druginjurycom/2015/05/testosterone-drugs-safety-shots-injections-strokes-heart-attacks-deaths-hospitalizations-medical-study-article.html
Posted by Tom Lamb on 5.15.15 in Personal Injury.
Accounting Coach – This blog is a part of a larger site called Accounting Coach created by CPA Harold Avercamp. While the site’s entire mission is to help make accounting fun and interesting for everyone, its most notable audience is students. The Accounting Coach blog regularly poses a single question with a detailed answer. For instance: “What is the employee’s Social Security tax rate for 2013?” It’s the perfect format for someone looking to test their skills and/or keep them sharp.
Posted by Daniel Lawry on 5.11.15 in Business - Banking.
Drug Injury Watch: Long-Term Combined Plavix - Effient Use May Be Associated With An Increased Overall Risk Of Non-Cardiovascular Death Compared To Shorter Therapy Period FDA Drug Safety Communication Issued In November 2014 About The Dual Antiplatelet Therapy (DAPT) Trial Which Was Published In The New England Journal of Medicine
Posted by Tom Lamb on 5.8.15 in Personal Injury.
Drug Injury Watch: With Zofran - Birth Defects Lawsuits Filed, How Will GlaxoSmithKline Update Its Drug Label To Comply With New FDA Rule Effective June 2015 New FDA Rule Requires Drug Company To Replace Current Simple Pregnancy Category Designation With A Summary Of The Risks Of Using Zofran During Pregnancy http://www.drug-injury.com/druginjurycom/2015/04/zofran-label-changes-pregnancy-use-risks-increased-birth-defects-lawsuits-glaxosmithkline-fda-rule-june-2015.html
Posted by Tom Lamb on 5.5.15 in Personal Injury.
Drug Injury Watch: Attention Deficit Hyperactivity Disorder Drugs Concerta And Ritalin Get New Warnings For Rhabdomyolysis In US And Priapism In Canada Muscle-Wasting Side Effect "Rhabdo" Seems To Apply To Entire ADHD Class Of Drugs Given That April 2015 FDA Letter Was Sent To All Manufacturers http://www.drug-injury.com/druginjurycom/2015/04/adhd-drugs-fda-label-changes-adderall-rhabdomyolysis-ritalin-priapism-conderta-safety-alert-health-canada.html
Posted by Tom Lamb on 4.27.15 in Personal Injury.
Drug Injury Watch: Diabetes Drugs Kombiglyze And Onglyza: Heart Failure Side Effect Seems To Be Valid, And FDA Notes There Is A Possible Increased Risk Of All-Cause Mortality As Analysis Did Not Reveal Causes Of The Increase In Death Incidents, FDA Asks Its Advisory Committee To Discuss This Safety Issue At April 2015 Meeting http://www.drug-injury.com/druginjurycom/2015/04/onglyza-heart-failure-kombiglyze-deaths-risks-increased-cardiovascular-side-effects-fda-astrazeneca-diabetes-drugs.html
Posted by Tom Lamb on 4.16.15 in Personal Injury.
Drug Injury Watch: A 2004 Medical Journal Article Indicated A Possible Link Between The "Morning Sickness" Drug Use Of Zofran And Hypospadias However, It Seems No Further Research About This Congenital Birth Defect Being Caused By Zofran Use During Pregnancy Has Been Done By GlaxoSmithKline http://www.drug-injury.com/druginjurycom/2015/04/zofran-safety-pregnancy-use-birth-defects-congenital-malformations-hypospadias-deformities-ondansetron-generics.html
Posted by Tom Lamb on 4.8.15 in Personal Injury.
Drug Injury Watch: In Canada, ADHD Drugs Like Adderall, Concerta, And Ritalin Are Getting New Warnings About Suicide-Related Adverse Events Increased Warning About The Risk Of Suicidal Thoughts And Behaviors Being Added To Attention Deficit Hyperactivity Disorder (ADHD) Drug Labels http://www.drug-injury.com/druginjurycom/2015/03/health-canada-adhd-drugs-warnings-suicides-adderall-concerta-ritalin-labels-revisions.html
Posted by Tom Lamb on 4.1.15 in Personal Injury.
Drug Injury Watch: Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice FDA Letters To AstraZeneca And Novo Nordisk Approve Addition Of Information About Increased Risk For Medullary Thyroid Carcinoma (MTC) http://www.drug-injury.com/druginjurycom/2015/03/bydureon-cancer-victoza-thyroid-carcinoma-label-changes-diabetes-drugs-fda-black-box-warnings.html
Posted by Tom Lamb on 3.24.15 in Personal Injury.
Drug Injury Watch: YAZ / Yasmin Litigation Update For March 2015: According To Bayer's 2014 Annual Report, "Additional lawsuits are anticipated." Bayer Claims It Settled About 300 Of These Cases While Another 1300 Lawsuits Were Filed From Mid-October 2014 To The End Of January 2015 http://www.drug-injury.com/druginjurycom/2015/03/bayer-reports-numbers-yaz-settlements-yasmin-cases-beyaz-lawsuits-safyral-claims-dvt-pe-deaths.html
Posted by Tom Lamb on 3.18.15 in Personal Injury.